Pronovotx

2 known investors

ProNovo Therapeutics is a biotechnology company developing precision small-molecule therapeutics for neuropsychiatric disorders, including Major Depressive Disorder and Schizophrenia. The company applies a precision-medicine approach based on genetic susceptibility, disease pathophysiology, and biomarkers to advance preclinical drug programs toward clinical development.

BiotechHealthtechMental Health